Whole Genome and Exome Sequencing Markets Report 2023-2027: Industry on Verge of Breakout in Healthcare, Consumer and Agricultural Markets
February 08, 2023 03:08 ET
|
Research and Markets
Dublin, Feb. 08, 2023 (GLOBE NEWSWIRE) -- The "Whole Genome and Exome Sequencing Markets by Application, Organism and Product with Executive and Consultant Guides. Includes Direct to Consumer...
GeneDx Makes Significant Industry-Wide Contributions to New Disease Gene Discovery
January 30, 2023 08:30 ET
|
GeneDx Holdings Corp.
Company submitted nearly one quarter of all candidate gene submissions to GeneMatcher in 2022 and collaborated on 63 publications involving new disease-gene associations or expansion of phenotype...
CRISPR Technology Global Markets Report 2023: A $9.2 Billion Market by 2027, from $3.3 Billion in 2022
January 25, 2023 04:08 ET
|
Research and Markets
Dublin, Jan. 25, 2023 (GLOBE NEWSWIRE) -- The "CRISPR Technology: Global Markets" report has been added to ResearchAndMarkets.com's offering. The current report provides detailed exposure to the...
Global Genomics Market Forecasts Report 2023-2027 - Increasing Demand of Specialized/Personalized Medicine Fueling Demand
January 19, 2023 05:58 ET
|
Research and Markets
Dublin, Jan. 19, 2023 (GLOBE NEWSWIRE) -- The "Genomics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Products & Services (Systems &...
Sema4 Announces Name Change to GeneDx and Provides Preliminary 2022 Financial Results and 2023 Guidance
January 09, 2023 08:30 ET
|
GeneDx Holdings Corp.
Company expects to exceed 2022 revenue target with strong momentum to deliver continued growth in 2023 combining GeneDx and Centrellis® platforms Company’s common stock will trade on the Nasdaq under...
Direct-To-Consumer (DTC) Genetic Testing Market Report 2022: Featuring 23 and Me, Gene by Gene, Quest Diagnostics & More
December 16, 2022 08:03 ET
|
Research and Markets
Dublin, Dec. 16, 2022 (GLOBE NEWSWIRE) -- The "Direct-To-Consumer (DTC) Genetic Testing Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive...
WellSpan Health and Helix announce partnership to improve patient health outcomes through new population genomics program
December 08, 2022 08:50 ET
|
WellSpan Health
York, Pa., Dec. 08, 2022 (GLOBE NEWSWIRE) -- WellSpan Health and Helix, the nation’s leading population genomics and viral surveillance company, announced today a partnership to create a...
Genome Engineering Global Market Report 2022: Increasing Funding and Investments for Research and Development Present Lucrative Opportunities
December 08, 2022 06:08 ET
|
Research and Markets
Dublin, Dec. 08, 2022 (GLOBE NEWSWIRE) -- The "Genome Engineering Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Technology (CRISPR, TALEN, ZFN,...
Epigenetics Global Market Report 2022: Increasing Investment and R&D Efforts Driving Growth
December 06, 2022 05:53 ET
|
Research and Markets
Dublin, Dec. 06, 2022 (GLOBE NEWSWIRE) -- The "Epigenetics Market By Product, By Application, By End User: Global Opportunity Analysis and Industry Forecast, 2020-2030" report has been added to ...
New Research from Sema4|GeneDx Highlights the Importance of Rapid Exome Sequencing for Diagnosing Mitochondrial Diseases in the NICU
December 05, 2022 08:00 ET
|
Sema4
STAMFORD, Conn., Dec. 05, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), a health insights company, today announced the results of a new study on mitochondrial diseases in newborns. The findings...